免疫疗法在局部晚期宫癌的前期确定的管理:一个不断变化的治疗范式
Christopher R Weil1, Jeffrey Brower2, William Small3
1The University of Texas MD Anderson Cancer Center, Division of Radiation Oncology, Houston, TX, 77030.
Practical radiation oncology
|December 8, 2025
概括
正在探索并发和辅助免疫疗法,以改善本地晚期宫癌患者的生存率. 大批量中心正在整合这些新的治疗方法,但需要进一步的研究来确定免疫治疗的最佳候选患者.
科学领域:
- 妇科瘤学 妇科瘤学
- 辐射瘤学 辐射瘤学
- 医学瘤学 医学瘤学
背景情况:
- 绝对化学辐射是局部晚期宫癌的标准,但生存结果仍然不理想.
- 放射治疗和支臂疗法的进步并没有显著改善患者的生存率.
- 在局部晚期的宫癌中,需要加强治疗策略.
研究的目的:
- 探索将免疫疗法纳入本地晚期宫癌的管理中.
- 了解大规模机构如何整合新型免疫疗法.
- 审查最近试验对临床实践的影响.
主要方法:
- 审查高人数机构的临床实践.
- 从前性随机III期试验 (CALLA和Keynote A18) 的数据分析.
- 探索并发和辅助免疫治疗方法.
主要成果:
- 两个主要的试验 (CALLA和Keynote A18) 研究了除了化疗辐射之外的免疫治疗.
- 大规模的机构正在积极探索免疫治疗的整合.
- 目前的数据表明,一种趋势是用免疫疗法加强治疗.
结论:
- 免疫疗法是局部晚期宫癌治疗强化的一个有希望的途径.
- 进一步的长期结果数据对于指导最佳患者选择至关重要.
- 未来的研究有必要确定一线免疫治疗的作用.
更多相关视频
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


